ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 5,250.00
-440.00 (-7.73%)
At close: Jun 2, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 390.41 billion as of June 3, 2026.
Market Cap
390.41B
Enterprise Value
371.47B
Revenue
59.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
5,250.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 390.41B, a decrease of -28.70%. That is a compound annual growth rate of -27.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 390.41B | -59.57% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 888.49B |
| Samyang Biopharm | 401.54B |
| HEM Pharma | 336.56B |
| NOVAREX | 252.70B |
| CellBion | 248.93B |
| DAE HWA Pharmaceutical | 213.35B |
| GC WellBeing | 165.38B |
| High Tech Pharm | 161.20B |